These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36631976)

  • 1. Vinblastine pharmacokinetics in mouse, dog, and human in the context of a physiologically based model incorporating tissue-specific drug binding, transport, and metabolism.
    Witta S; Collins KP; Ramirez DA; Mannheimer JD; Wittenburg LA; Gustafson DL
    Pharmacol Res Perspect; 2023 Feb; 11(1):e01052. PubMed ID: 36631976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered pharmacokinetics of vinblastine in Mdr1a P-glycoprotein-deficient Mice.
    van Asperen J; Schinkel AH; Beijnen JH; Nooijen WJ; Borst P; van Tellingen O
    J Natl Cancer Inst; 1996 Jul; 88(14):994-9. PubMed ID: 8667431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic modeling of doxorubicin pharmacokinetics in dogs deficient in ABCB1 drug transporters.
    Gustafson DL; Thamm DH
    J Vet Intern Med; 2010; 24(3):579-86. PubMed ID: 20337920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporation of ABCB1-mediated transport into a physiologically-based pharmacokinetic model of docetaxel in mice.
    Hudachek SF; Gustafson DL
    J Pharmacokinet Pharmacodyn; 2013 Aug; 40(4):437-49. PubMed ID: 23616082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of a "Fit for Purpose" PBPK Model to Investigate the CYP3A4 Induction Potential of Enzalutamide.
    Narayanan R; Hoffmann M; Kumar G; Surapaneni S
    Drug Metab Lett; 2016; 10(3):172-179. PubMed ID: 27604990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of furanocoumarin derivatives in grapefruit juice on the uptake of vinblastine by Caco-2 cells and on the activity of cytochrome P450 3A4.
    Ohnishi A; Matsuo H; Yamada S; Takanaga H; Morimoto S; Shoyama Y; Ohtani H; Sawada Y
    Br J Pharmacol; 2000 Jul; 130(6):1369-77. PubMed ID: 10903978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Physiologically Based Pharmacokinetic Model of Voriconazole Integrating Time-Dependent Inhibition of CYP3A4, Genetic Polymorphisms of CYP2C19 and Predictions of Drug-Drug Interactions.
    Li X; Frechen S; Moj D; Lehr T; Taubert M; Hsin CH; Mikus G; Neuvonen PJ; Olkkola KT; Saari TI; Fuhr U
    Clin Pharmacokinet; 2020 Jun; 59(6):781-808. PubMed ID: 31853755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiologically Based Pharmacokinetic Modeling to Simulate CYP3A4-Mediated Drug-Drug Interactions for Pyrotinib.
    Ni L; Zheng L; Liu Y; Xu W; Zhao Y; Wang L; Zhang Q; Hu W; Chen X
    Adv Ther; 2023 Oct; 40(10):4310-4320. PubMed ID: 37455292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic effects of capsaicin on vinblastine in rats mediated by CYP3A and Mrp2.
    Zhai X; Feng Y; Liu J; Li J; Zong Y; Tuo Z; Gao S; Lv Y
    Fundam Clin Pharmacol; 2019 Aug; 33(4):376-384. PubMed ID: 30632627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of drug transport kinetics in multidrug-resistant cells using a novel coumarin-vinblastine compound.
    Bornmann WG; Roepe PD
    Biochemistry; 1994 Oct; 33(42):12665-75. PubMed ID: 7918493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sorafenib metabolism, transport, and enterohepatic recycling: physiologically based modeling and simulation in mice.
    Edginton AN; Zimmerman EI; Vasilyeva A; Baker SD; Panetta JC
    Cancer Chemother Pharmacol; 2016 May; 77(5):1039-52. PubMed ID: 27053087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of intercorrelation between hepatic CYP3A4-CYP2C8 enzymes for the evaluation of drug-drug interactions: a case study with repaglinide.
    Doki K; Darwich AS; Achour B; Tornio A; Backman JT; Rostami-Hodjegan A
    Br J Clin Pharmacol; 2018 May; 84(5):972-986. PubMed ID: 29381228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P-glycoprotein, multidrug-resistance associated protein 2, Cyp3a, and carboxylesterase affect the oral availability and metabolism of vinorelbine.
    Lagas JS; Damen CW; van Waterschoot RA; Iusuf D; Beijnen JH; Schinkel AH
    Mol Pharmacol; 2012 Oct; 82(4):636-44. PubMed ID: 22767610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A generic framework for the physiologically-based pharmacokinetic platform qualification of PK-Sim and its application to predicting cytochrome P450 3A4-mediated drug-drug interactions.
    Frechen S; Solodenko J; Wendl T; Dallmann A; Ince I; Lehr T; Lippert J; Burghaus R
    CPT Pharmacometrics Syst Pharmacol; 2021 Jun; 10(6):633-644. PubMed ID: 33946131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Multiple Concomitant CYP3A Inhibitors on Venetoclax Pharmacokinetics: A PBPK and Population PK-Informed Analysis.
    Mukherjee D; Brackman DJ; Suleiman AA; Zha J; Menon RM; Salem AH
    J Clin Pharmacol; 2023 Jan; 63(1):119-125. PubMed ID: 35996877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiologically based pharmacokinetic modeling to predict complex drug-drug interactions: a case study of AZD2327 and its metabolite, competitive and time-dependent CYP3A inhibitors.
    Guo J; Zhou D; Li Y; Khanh BH
    Biopharm Drug Dispos; 2015 Nov; 36(8):507-19. PubMed ID: 26081137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiologically Based Pharmacokinetic Models for Adults and Children Reveal a Role of Intracellular Tubulin Binding in Vincristine Disposition.
    Lee CM; Zane NR; Veal G; Thakker DR
    CPT Pharmacometrics Syst Pharmacol; 2019 Oct; 8(10):759-768. PubMed ID: 31420944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model qualification of the PK-Sim® pediatric module for pediatric exposure assessment of CYP450 metabolized compounds.
    Yun YE; Edginton AN
    J Toxicol Environ Health A; 2019; 82(14):789-814. PubMed ID: 31405354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiologically based pharmacokinetic modeling and simulation to predict drug-drug interactions of ivosidenib with CYP3A perpetrators in patients with acute myeloid leukemia.
    Prakash C; Fan B; Ke A; Le K; Yang H
    Cancer Chemother Pharmacol; 2020 Nov; 86(5):619-632. PubMed ID: 32978634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resurgence in the use of physiologically based pharmacokinetic models in pediatric clinical pharmacology: parallel shift in incorporating the knowledge of biological elements and increased applicability to drug development and clinical practice.
    Johnson TN; Rostami-Hodjegan A
    Paediatr Anaesth; 2011 Mar; 21(3):291-301. PubMed ID: 20497354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.